Article
The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
Pharmacogenetics and genomics - 1 Jun 2017
Moriyama Takaya, Nishii Rina, Lin Ting-Nien, Kihira Kentaro, Toyoda Hidemi, Jacob Nersting, Kato Motohiro, Koh Katsuyoshi, Inaba Hiroto, Manabe Atsushi, Schmiegelow Kjeld, Yang Jun J, Hori Hiroki
Abstract excerpt
Thiopurines [e.g. mercaptopurine (MP)] are widely used as chemotherapeutic agents in the treatment of pediatric acute lymphoblastic leukemia with dose-limiting hematopoietic toxicity. Recently, germline variants in NUDT15 have been identified as a major genetic cause for MP-related bone marrow suppression, and there is increasing interest in the clinical implementation of NUDT15 genotype-guided MP dose...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
